Individuals who are homozygous for the UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) *28 allele are at increased risk for neutropenia following initiation of irinotecan treatment, and a reduction in the starting dose should be considered for these patients.(12). Here, UGT1A1 is linked to Decreased total neutrophil count.